Where Can You Get Testosterone Shots? 4 Safe Options

Why the Source of Your Testosterone Prescription Matters

Getting testosterone from a legitimate medical provider protects your health in ways that gray-market purchases cannot. The American Urological Association (AUA) 2018 guideline on testosterone deficiency requires confirmation of low testosterone on two separate morning samples before initiating therapy, plus baseline hematocrit, PSA, and metabolic labs.

Skipping this diagnostic step exposes men to polycythemia (dangerously elevated red blood cells), undiagnosed prostate pathology, and cardiovascular events. A 2010 Testosterone in Older Men with Mobility Limitations (TOM) trial (N=209) was stopped early after testosterone-treated men over age 65 with mobility limitations experienced a higher rate of cardiovascular adverse events compared to placebo [1]. That finding led to the FDA's 2015 label update requiring cardiovascular risk warnings on all testosterone products. A qualified provider accounts for these risks before writing a prescription.

The Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) trial (N=5,246) later demonstrated that testosterone cypionate 1.62% gel did not increase major adverse cardiovascular events over a mean follow-up of 33 months in men aged 45 to 80 with pre-existing or high risk of cardiovascular disease [2]. This reassured clinicians that TRT is safe when prescribed appropriately with monitoring. The distinction is clear: supervised therapy with regular labs is safe; unmonitored use is not.

Option 1: Dedicated Men's Health and TRT Clinics

Specialized TRT clinics are the fastest path from symptom recognition to treatment. These clinics perform in-house blood draws, often return results within 24 to 48 hours, and have protocols specifically designed around male hormone optimization.

A typical first visit includes a comprehensive metabolic panel, total and free testosterone, SHBG, LH, FSH, estradiol, hematocrit, PSA, and a lipid panel. If your total testosterone falls below 300 ng/dL on two morning draws (or below 220 ng/dL on a single draw with clear symptoms), most clinic protocols initiate treatment the same week. The Endocrine Society's 2018 Clinical Practice Guideline recommends testosterone therapy for men with unequivocally low testosterone and symptoms consistent with deficiency [3].

Clinics generally stock testosterone cypionate (the most commonly prescribed ester in the U.S.) and teach patients to self-inject at home using intramuscular or subcutaneous technique. A 2022 randomized crossover study published in the Journal of Clinical Endocrinology & Metabolism found that subcutaneous testosterone cypionate 75 mg weekly produced equivalent serum testosterone levels to intramuscular injection with fewer reported injection-site reactions [4].

Expect follow-up labs at 6 weeks, 3 months, then every 6 to 12 months. Costs range from $150 to $300 per month all-inclusive (labs, medication, provider visits) for patients paying out of pocket.

Option 2: Telehealth Platforms With Licensed Prescribers

Telehealth TRT has become the second most common entry point for men starting testosterone therapy. Platforms connect patients with licensed physicians or nurse practitioners via video consultation, order labs at a local draw site, and ship medication directly to the patient's home.

The workflow typically proceeds in four steps: complete an online intake questionnaire, get blood drawn at a partner lab (Quest, Labcorp, or a mobile phlebotomy service), attend a video consultation to review results, and receive medication by mail if clinically appropriate. Total turnaround from intake to first injection averages 7 to 14 days.

Telehealth prescribers follow the same AUA and Endocrine Society guidelines as in-person providers. A 2021 cross-sectional analysis published in Urology found that among 340 men initiated on TRT through telehealth, 94% had appropriately documented baseline labs and 88% completed 6-month follow-up labs [5]. These compliance rates matched or exceeded those seen in traditional urology practices.

Legitimate telehealth platforms require at minimum two low testosterone readings, screen for contraindications (untreated polycythemia, active breast or prostate cancer, untreated severe sleep apnea, desire for near-term fertility), and establish a monitoring schedule. Red flags that indicate a platform is not following standard of care include prescribing without labs, not asking about fertility goals, or offering testosterone to men with normal hormone levels for "optimization" above physiologic range.

Monthly costs on telehealth platforms range from $100 to $250 including medication, provider access, and lab orders. Generic testosterone cypionate 200 mg/mL (10 mL vial) costs approximately $30 to $50 at retail pharmacy with a GoodRx coupon, so much of the platform fee covers provider time and convenience.

Option 3: Urologists Specializing in Male Hormonal Health

Urologists are the specialists most frequently managing testosterone deficiency alongside its reproductive implications. This matters because exogenous testosterone suppresses spermatogenesis. Men who want to preserve fertility need a provider who understands how to manage that tradeoff.

A urologist will typically offer alternatives to testosterone for men concerned about fertility. These include clomiphene citrate (off-label, 25 to 50 mg every other day), human chorionic gonadotropin (hCG) monotherapy or co-administration with testosterone, and enclomiphene. The AUA guideline explicitly recommends against testosterone monotherapy in men desiring fertility and suggests these alternatives [1].

For men who do not need to preserve fertility, urologists prescribe standard testosterone cypionate or enanthate at doses of 100 to 200 mg intramuscularly every 7 to 14 days, or 50 to 100 mg subcutaneously weekly. They also manage complications that TRT clinics may not handle as comprehensively: secondary erythrocytosis requiring therapeutic phlebotomy, rising PSA requiring prostate biopsy referral, or gynecomastia requiring estradiol management with anastrozole.

A referral is not always required. Many urology practices accept self-referred patients. Wait times for a new patient appointment average 2 to 6 weeks depending on geography. Insurance coverage for the visit itself is standard; coverage for testosterone medication varies by plan but is increasingly common for documented hypogonadism with ICD-10 code E29.1.

The 2020 AUA Census reported that approximately 68% of practicing urologists manage testosterone deficiency as part of their clinical scope [6]. Your likelihood of finding an experienced TRT prescriber in a urology practice is high.

Option 4: Endocrinologists Managing Complex Hormonal Disorders

Endocrinologists are the appropriate choice when testosterone deficiency has a secondary or complex etiology. Secondary hypogonadism (low testosterone caused by pituitary or hypothalamic dysfunction rather than testicular failure) requires investigation of prolactin levels, pituitary MRI, iron studies for hemochromatosis, and assessment of other pituitary axes.

If your LH and FSH are low or inappropriately normal alongside low testosterone, an endocrinologist can determine whether the cause is a pituitary adenoma, hyperprolactinemia, prior anabolic steroid use, obesity-related hypothalamic suppression, or genetic conditions like Kallmann syndrome. The Endocrine Society guideline recommends measuring LH, FSH, and prolactin in all men with confirmed low testosterone to distinguish primary from secondary hypogonadism [3].

Endocrinologists also manage TRT in the context of concurrent metabolic disease. Men with type 2 diabetes have a 2-fold higher prevalence of hypogonadism compared to men without diabetes, according to a meta-analysis of 14 observational studies (N=3,825) published in the International Journal of Impotence Research [7]. In these patients, testosterone therapy produced a mean reduction in HbA1c of 0.94% over 12 months alongside improvements in insulin sensitivity and visceral adiposity.

The tradeoff with endocrinology referrals is access. The U.S. has approximately 7,500 practicing endocrinologists, and wait times for new patients average 3 to 8 weeks in metropolitan areas and longer in rural regions. Many endocrinologists prioritize diabetes and thyroid management, so explicitly requesting a provider with experience in male hypogonadism when scheduling is advisable.

How to Choose Between the Four Options

Your clinical situation determines which provider type fits best. A straightforward case (symptomatic man aged 30 to 55, clearly low testosterone on two draws, no fertility concerns, no complex medical history) is well-served by a TRT clinic or telehealth platform. These routes are faster and often less expensive out of pocket.

A man who wants to start a family within the next 1 to 2 years should see a urologist who can manage fertility-sparing protocols. A man with LH below 2 mIU/mL, a history of pituitary surgery, or testosterone deficiency alongside thyroid or adrenal abnormalities should see an endocrinologist.

The non-negotiable across all four options: two confirmed low testosterone readings, baseline hematocrit and PSA, a discussion of risks (including the TRAVERSE findings and fertility impact), and a commitment to follow-up labs. Any provider who skips these steps is not practicing within guideline-recommended care.

What Testosterone Formulations Are Available Through These Providers

All four provider types can prescribe the same FDA-approved testosterone formulations. The choice depends on patient preference, insurance formulary, and clinical factors.

Testosterone cypionate injection remains the most widely prescribed formulation in the U.S. due to its low cost ($30 to $50 per month generic), predictable pharmacokinetics, and dosing flexibility. Standard doses range from 100 to 200 mg intramuscularly every 7 to 14 days or 50 to 100 mg subcutaneously weekly. Half-life is approximately 8 days, producing a peak at 24 to 48 hours post-injection followed by a gradual decline [8].

Testosterone enanthate has nearly identical pharmacokinetics and is interchangeable at the same dose. Testosterone undecanoate (Aveed) provides a long-acting option at 750 mg intramuscularly every 10 weeks after a loading phase, but carries an FDA-mandated REMS program due to rare post-injection pulmonary oil microembolism and must be administered in a healthcare setting with 30-minute observation.

Topical gel (AndroGel, Testim, Vogelxo) at 1% or 1.62% concentration applied daily offers needle-free administration but introduces transference risk to household contacts and has variable absorption. Nasal gel (Natesto) dosed three times daily avoids transference but requires strict adherence. Oral testosterone undecanoate (Jatenzo) dosed twice daily with a fat-containing meal provides the only FDA-approved oral option without hepatotoxicity concerns, though cost exceeds $500 per month without insurance.

What to Expect at Your First Appointment

Regardless of which provider type you choose, your first visit follows a predictable sequence. Bring any prior lab results. If you have not had labs drawn, the provider will order them before prescribing anything.

The standard initial lab panel includes: total testosterone (drawn between 7:00 and 10:00 AM), free testosterone or SHBG, complete blood count (specifically hematocrit), comprehensive metabolic panel, lipid panel, PSA (for men over 40 or with family history of prostate cancer), LH, and FSH. Some providers add estradiol, prolactin, and thyroid function tests.

If both testosterone values return below 300 ng/dL and you have symptoms (fatigue, reduced libido, erectile dysfunction, depressed mood, decreased muscle mass, increased body fat), treatment initiation is appropriate. The provider will discuss formulation options, teach injection technique if applicable, and schedule a 6-week follow-up lab to assess trough testosterone levels and hematocrit response.

Target trough testosterone on therapy is 400 to 700 ng/dL per AUA guidelines, with dose adjustments made based on symptoms and labs rather than chasing a specific number. Hematocrit above 54% requires dose reduction, increased injection frequency (smaller doses more often produce less erythrocytosis), or therapeutic phlebotomy.

Red Flags That a Provider Is Not Following Standard of Care

Not all testosterone prescribers practice safely. Watch for these warning signs: prescribing without labs, prescribing based on a single testosterone reading, not discussing fertility implications, not monitoring hematocrit, targeting supraphysiologic levels (above 1 to 100 ng/dL), or prescribing testosterone to men with normal levels who want "performance enhancement."

The FDA's approved labeling restricts testosterone products to men with confirmed hypogonadism due to conditions of the testes, pituitary, or hypothalamus [9]. Prescribing for age-related "low-T" symptoms without documented biochemical deficiency falls outside this indication, though the Endocrine Society acknowledges that symptomatic men with borderline levels (200 to 300 ng/dL) may benefit from a therapeutic trial with close monitoring.